Genomics Investment Burns Bright in Void of Dot-Com Retreat | GenomeWeb

NEW YORK, Aug. 20 – Venture capital investment in US biotechnology companies, which include genomic and bioinformatics firms, has increased by $100 million to $1.1 billion since the beginning of the year, even as overall venture financing plunged by 58 percent to $25 billion, according to a recent analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.